Showing results (991-1000 of 1,022) with videos related to

Sort By:
Pageof 103
European Journal of Cancer (Oxford, England : 1990)|October 4, 2022
Efficacy comparison between anti-PD-1 antibody monotherapy and anti-PD-1 plus anti-CTLA-4 combination therapy as first-line immunotherapy for advanced acral melanoma: A retrospective, multicenter study of 254 Japanese patientsYasuhiro Nakamura, Kenjiro Namikawa, Yukiko Kiniwa, et al.
European Journal of Cancer (Oxford, England : 1990)|September 26, 2021
Real-world efficacy of anti-PD-1 antibody or combined anti-PD-1 plus anti-CTLA-4 antibodies, with or without radiotherapy, in advanced mucosal melanoma patients: A retrospective, multicenter studyYoshiyasu Umeda, Shusuke Yoshikawa, Yukiko Kiniwa, et al.
Experimental Dermatology|January 8, 2026
Phase III Study Investigating the Safety and Efficacy of TM5614 in Combination With Nivolumab for the Treatment of Unresectable Malignant Melanoma: ProtocolTaku Fujimura, Koji Yoshino, Hiroshi Kato, et al.
DEN Open|March 4, 2024
Multicenter study of invasive gastric cancer detected after 10 years of <i>Helicobacter pylori</i> eradication in Japan: Clinical, endoscopic, and histopathologic characteristicsMasaaki Kobayashi, Junko Fujisaki, Ken Namikawa, et al.
Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society|September 28, 2025
Clinical Features of Invasive Gastric Cancer Developed After Helicobacter pylori Eradication During Regular Endoscopic SurveillanceAkiko Sasaki, Junko Fujisaki, Masaaki Kobayashi, et al.
The Journal of Dermatology|June 13, 2025
Japanese Dermatological Association Guidelines: Clinical Questions of Guidelines for Melanoma 2025Satoshi Fukushima, Takamichi Ito, Jun Asai, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 6, 2020
Real-world efficacy and safety of 12-week sofosbuvir/velpatasvir treatment for patients with decompensated liver cirrhosis caused by hepatitis C virus infectionYoshinari Takaoka, Kouichi Miura, Naoki Morimoto, et al.
International Journal of Clinical Oncology|April 7, 2025
Melanoma skin cancer statistics derived from 7442 Japanese patients: Japanese melanoma studyYasuhiro Fujisawa, Shusuke Yoshikawa, Tatsuya Takenouchi, et al.
ESMO Open|November 28, 2021
Anti-PD-1 antibody monotherapy versus anti-PD-1 plus anti-CTLA-4 combination therapy as first-line immunotherapy in unresectable or metastatic mucosal melanoma: a retrospective, multicenter study of 329 Japanese cases (JMAC study)Y Nakamura, K Namikawa, S Yoshikawa, et al.
ESMO Open|April 13, 2024
The impact of rare cancer and early-line treatments on the benefit of comprehensive genome profiling-based precision oncologyT Kubo, K Sunami, T Koyama, et al.
Pageof 103